Carlos Bonilla
Corporate Officer/Principal bij Carlos J. Bonilla & Associates PL
Vermogen: 1 M $ op 31-05-2024
Actieve functies van Carlos Bonilla
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Carlos J. Bonilla & Associates PL | Corporate Officer/Principal | 12-05-2011 | - |
Loopbaan van Carlos Bonilla
Eerdere bekende functies van Carlos Bonilla
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
XenaCare Holdings, Inc.
 XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Directeur/Bestuurslid | 25-03-2011 | - |
| Independent Dir/Board Member | 24-03-2011 | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
XenaCare Holdings, Inc.
XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Health Technology |
| Carlos J. Bonilla & Associates PL |
- Beurs
- Insiders
- Carlos Bonilla
- Ervaring
